Prognostic value of immune checkpoint molecules in breast cancer

Immune checkpoint blockade treatments bring remarkable clinical benefits to fighting several solid malignancies. However, the efficacy of immune checkpoint blockade in breast cancer remains controversial. Several clinical trials of immune checkpoint blockades focused on the effect of CTLA4 and PD1/P...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Jun, Chen, Feng, Liu, Dong, Gu, Feiying, Chen, Zhigang, Wang, Yuezhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340863/
https://www.ncbi.nlm.nih.gov/pubmed/32602545
http://dx.doi.org/10.1042/BSR20201054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340863/
https://www.ncbi.nlm.nih.gov/pubmed/32602545
http://dx.doi.org/10.1042/BSR20201054

Ejemplares similares